Pituitary & hypothalamus

Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis

PituitaryPublished Retrospective cohort study

Authors' conclusion

Adenomas < 20 mm showed lower morbidity and better therapeutic response in acromegaly, while those ≥ 20 mm had similar clinical, therapeutic, and prognostic behavior.

Study context

Population
Patients with acromegaly (growth hormone (GH)-secreting pituitary adenoma) followed at a tertiary center; 59 women, age at diagnosis 43 ± 13 years
Participants
117 patients
Exposure
Adenoma size groups at diagnosis
  • In = 11
  • IIn = 54
  • IIIn = 34
  • IVn = 10
  • Vn = 8
Outcome
Characteristics by adenoma size
Methodological detailsobservational, single-center
  • Observational
  • Single-center

Main finding

As reported in the abstract

  • Prevalence of hypopituitarism, cavernous sinus invasion, GH levels and SRL use increased with adenoma size
  • Age correlated negatively with tumor size
  • Tumor diameter around 20 mm was the best predictor of hypopituitarism, invasiveness, need of adjuvant therapies and poorer disease control

Observational data: associations, not effects.

Original publication

Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis. Pituitary. Published 1 August 2024. doi:10.1007/s11102-024-01432-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.